Skip to content
Trial Eligibility
Menu

Expanding Access to Cervical Cancer Screening Through Primary HR-HPV Testing and Self-sampling: a Multicomponent Intervention for Safety Net Health Systems

NCT06843720

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

To learn about the attitudes toward implementing self-collection among healthcare providers and staff, participants, and other stakeholders; and to inform the development of patient education and provider training materials to aid in the implementation of self-collection in clinical settings.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HR-HPV Testing

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 65 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
M.D. Anderson Cancer Center
Last updated on ClinicalTrials.gov
June 23, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Texas · 1

  • MD Anderson Cancer Center · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.